Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
about
Role of PD-1 in HIV pathogenesis and as target for therapyNatural history of chronic hepatitis B virus infection from infancy to adult life - the mechanism of inflammation triggering and long-term impactsAcute Malaria Induces PD1+CTLA4+ Effector T Cells with Cell-Extrinsic Suppressor FunctionCD24 polymorphisms affect risk and progression of chronic hepatitis B virus infectionProgrammed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usageChronically inflamed livers up-regulate expression of inhibitory B7 family members.Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infectionExpression of hepatitis B virus x protein in hepatocytes suppresses CD8 T cell activity.Programmed death-1 expression on HIV-1-specific CD8+ T cells is shaped by epitope specificity, T-cell receptor clonotype usage and antigen load.PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model.Liver immunology.IL-10 mediated regulation of liver inflammation during acute murine cytomegalovirus infectionNatural killer cells are characterized by the concomitantly increased interferon-γ and cytotoxicity in acute resolved hepatitis B patients.Polymorphisms in programmed death-1 gene are not associated with chronic HBV infection in Chinese patients.Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection.Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactionsImmune mediated liver failure.PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell KillingConstitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy.Plasmacytoid dendritic cells promote HIV-1-induced group 3 innate lymphoid cell depletion.Virus-specific CD8+ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replicationStudy of human B7 homolog 1 expression in patients with hepatitis B virus infectionViral acute lower respiratory infections impair CD8+ T cells through PD-1Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B.Transcriptome-Wide Analysis of Hepatitis B Virus-Mediated Changes to Normal Hepatocyte Gene Expression.Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovirCostimulatory and Coinhibitory Receptor Pathways in Infectious DiseaseHigh production rates sustain in vivo levels of PD-1high simian immunodeficiency virus-specific CD8 T cells in the face of rapid clearance.Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients.The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses.Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma.Programmed death-1 expression is associated with the disease status in hepatitis B virus infection.Myeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR ζ chain expression on CD8(+) T cells in chronic hepatitis C patients.Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.Fallen angels or risen apes? A tale of the intricate complexities of imbalanced immune responses in the pathogenesis and progression of immune-mediated and viral cancers.B and T lymphocyte attenuator down-regulation by HIV-1 depends on type I interferon and contributes to T-cell hyperactivation.Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection.Inhibitory receptor molecules in chronic hepatitis B and C infections: novel targets for immunotherapy?Immunopathogenesis of hepatitis B persistent infection: implications for immunotherapeutic strategies.Acute-on-chronic liver failure: recent update.
P2860
Q24634293-9BFEF093-6B0D-4926-8151-9A93E2268F9AQ26781165-DF830C13-9B28-4598-906D-9B46A6E04279Q28109688-51BC7622-C4F4-4BB5-8EF8-3731B6D6E222Q28252325-66B27248-0EF2-49DF-8343-520172A09007Q28749172-44A46909-EEC7-4A92-A21F-E987DB677857Q30434304-D763A02F-939D-4DEA-B98B-7F81CA1B5E28Q34072838-5B2D71E3-70A3-48D6-BBF4-22B47817B529Q34127443-7406E9EC-183F-4F86-A60D-D54310E9224FQ34197037-08F3F216-0D39-4A00-B9AF-9C4D7D71A5BEQ34325908-B79DBE26-5F05-4935-817E-013FA14DFD6BQ34359990-F4EDD594-13DE-476F-8168-E9E6DF7E67D0Q34374800-B2E88ED0-89D4-4BBD-8A0E-CBECCF3E2F45Q34469926-B14281E5-636D-4932-A053-2A4914352E0EQ34779172-C46A92E5-B471-48F6-A7A2-FAE82975AC79Q35082215-F7D87863-780B-476B-A7EC-DEA89155B393Q35422283-FBF067F2-AFE4-449C-85E9-99291CF3834FQ35729249-BE9B3636-584C-45B8-9915-838507AFC825Q35814368-2EBB8057-5542-459B-9E30-F9385E9B4784Q35875897-344986AE-3C04-4570-AF60-901F9D636523Q36106065-5FAF0DF2-7F2B-42A4-926C-44279321842FQ36109339-65F3BAC9-3189-4FE9-8625-C98ACA333CDAQ36121216-E3A8E526-8AA3-496B-8975-7F361EE4EE57Q36129102-C2753E87-A9D1-4FC8-82CE-6C3802D5A30DQ36476515-932CDC7A-6915-412C-86B9-54847B309393Q36593582-945FF885-5EC1-482E-8870-A2C6BAE2899DQ36715522-1F0D170F-1674-48F2-9B04-A0722F7253F8Q36919711-24A2CE8A-6AA2-41AD-B73D-AD47CA7FB91EQ37123414-33496018-F089-42BF-96D7-EAF0CC039C40Q37158244-EB844614-5086-4251-9B8C-311EDB915345Q37287296-271AEEF2-9796-4A4D-89D4-B20A60BBBCA4Q37295612-D34E8C82-C317-429B-9B7F-4AB0A96A1697Q37316915-DC93CB70-AAD0-4229-9571-67739D0B1227Q37532685-7DA56A0F-7C12-4AEA-95FB-7807E3DC1483Q37611853-A7924E58-3AD7-40F1-841B-89AEF8AE0231Q37620568-D1F52B60-5D54-4829-9516-2699F2C522E5Q37705556-AC3436EA-78EC-497B-8797-D58F834783E4Q37946440-F3AFAD52-D15B-4D5C-99B8-07538E725D61Q38206528-C56C5FE8-FB70-4091-8DBA-AB8AC6BA7026Q38550639-2F234FE7-F818-4A91-BDF7-C3309CC24805Q38698971-C905F80F-9197-415E-A850-4397F1FE768A
P2860
Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Dynamic programmed death 1 exp ...... outcome of acute hepatitis B.
@en
Dynamic programmed death 1 exp ...... outcome of acute hepatitis B.
@nl
type
label
Dynamic programmed death 1 exp ...... outcome of acute hepatitis B.
@en
Dynamic programmed death 1 exp ...... outcome of acute hepatitis B.
@nl
prefLabel
Dynamic programmed death 1 exp ...... outcome of acute hepatitis B.
@en
Dynamic programmed death 1 exp ...... outcome of acute hepatitis B.
@nl
P2093
P1433
P1476
Dynamic programmed death 1 exp ...... e outcome of acute hepatitis B
@en
P2093
Bao-Sen Li
E John Wherry
Fu-Sheng Wang
George K K Lau
Hui-Feng Wang
Ji-Yuan Zhang
Shu-Ye Zhang
P304
1938-49, 1949.e1-3
P356
10.1053/J.GASTRO.2008.03.037
P407
P50
P577
2008-03-22T00:00:00Z